全文获取类型
收费全文 | 1022篇 |
免费 | 76篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 24篇 |
妇产科学 | 3篇 |
基础医学 | 208篇 |
口腔科学 | 14篇 |
临床医学 | 83篇 |
内科学 | 202篇 |
皮肤病学 | 4篇 |
神经病学 | 15篇 |
特种医学 | 205篇 |
外科学 | 74篇 |
综合类 | 12篇 |
一般理论 | 1篇 |
预防医学 | 29篇 |
眼科学 | 13篇 |
药学 | 41篇 |
中国医学 | 1篇 |
肿瘤学 | 207篇 |
出版年
2019年 | 6篇 |
2018年 | 7篇 |
2015年 | 18篇 |
2014年 | 14篇 |
2013年 | 22篇 |
2012年 | 10篇 |
2011年 | 21篇 |
2010年 | 17篇 |
2009年 | 24篇 |
2008年 | 20篇 |
2007年 | 44篇 |
2006年 | 31篇 |
2005年 | 27篇 |
2004年 | 16篇 |
2003年 | 18篇 |
2002年 | 24篇 |
2001年 | 18篇 |
2000年 | 9篇 |
1999年 | 21篇 |
1998年 | 35篇 |
1997年 | 42篇 |
1996年 | 42篇 |
1995年 | 39篇 |
1994年 | 54篇 |
1993年 | 30篇 |
1992年 | 18篇 |
1991年 | 18篇 |
1990年 | 24篇 |
1989年 | 47篇 |
1988年 | 49篇 |
1987年 | 46篇 |
1986年 | 42篇 |
1985年 | 34篇 |
1984年 | 23篇 |
1983年 | 16篇 |
1982年 | 22篇 |
1981年 | 17篇 |
1980年 | 16篇 |
1979年 | 19篇 |
1978年 | 20篇 |
1977年 | 8篇 |
1976年 | 15篇 |
1975年 | 17篇 |
1974年 | 7篇 |
1970年 | 5篇 |
1969年 | 5篇 |
1968年 | 13篇 |
1967年 | 6篇 |
1966年 | 5篇 |
1965年 | 5篇 |
排序方式: 共有1140条查询结果,搜索用时 15 毫秒
1.
Edward M Messing Judith Manola George Wilding Kathleen Propert Jonathan Fleischmann E David Crawford J Edson Pontes Richard Hahn Donald Trump 《Journal of clinical oncology》2003,21(7):1214-1222
PURPOSE: To evaluate the role of adjuvant interferon alfa after complete resection of locally extensive renal cell carcinoma. PATIENTS AND METHODS: A total of 283 eligible patients with pT3-4a and/or node-positive disease were randomly assigned after radical nephrectomy and lymphadenectomy to observation or to interferon alfa-NL (Wellferon, Burroughs-Wellcome, Research Park, NC) given daily for 5 days every 3 weeks for up to 12 cycles. Patients were stratified on the basis of pathologic stage. Patients remained on treatment until documented recurrence, excessive toxicity, or patient/physician preference deemed removal appropriate. RESULTS: At median follow-up of 10.4 years, median survival was 7.4 years in the observation arm and 5.1 year in the treatment arm (log-rank P =.09). Median recurrence-free survival was 3.0 years in the observation arm and 2.2 years in the interferon arm (P =.33). Performance status (P =.003), nodal status (N2 v N0, P <.0001), and tumor stage (P =.0002) were significant prognostic factors in multivariate analysis. A proportional hazards model examining the effects of treatment arm and time to recurrence on survival after recurrence among patients who recurred found that random assignment to interferon treatment (P =.009) and shorter time to recurrence (P <.0001) were independent predictors of shorter survival after recurrence. Although no lethal toxicities were observed, severe (grade 4) toxicities including neutropenia, myalgia, fatigue, depression, and other neurologic toxicities occurred in 11.4% of those randomly assigned to interferon treatment. CONCLUSION: Adjuvant treatment with interferon did not contribute to survival or relapse-free survival in this group of patients. 相似文献
2.
3.
4.
B F Trump T W Jones K A Elliget M W Smith P C Phelps A Maki I K Berezesky 《Renal failure》1990,12(3):183-191
Cellular toxicity and cellular carcinogenesis are closely linked. In the kidney, this relationship has been emphasized by the recent discovery of a number of putatively non-mutagenic chemicals that result in acute and chronic toxicity and ultimately in carcinogenesis, especially in the male rat. Many, but not all such compounds, result in renal PTE phagolysosomal overload. At the same time, known metabolites of other carcinogens, e.g., HCBD and FBPA, result in acute renal injury and/or necrosis, followed by chronic tubular disease, interstitial nephritis, and ultimately carcinogenesis. A series of cell mechanisms have been suggested that lead from acute cell injury to altered control of cell division. These mechanisms appear to involve ion deregulation, (especially [Ca2+]i) resulting from a variety of continued injuries, (e.g., oxidative stress from inflammatory cells) and ultimately leading to altered gene expression. 相似文献
5.
SUMMARY A case congenital dislocation of both knees and dislocation of the left hip in an infant whose mother had a chronic amniotic fluid leakage after mid-trimester amniocentesis. 相似文献
6.
7.
Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. 总被引:10,自引:0,他引:10
S Kato P G Shields N E Caporaso R N Hoover B F Trump H Sugimura A Weston C C Harris 《Cancer research》1992,52(23):6712-6715
8.
9.
高效液相色谱法测定右旋儿茶素血浆浓度及药代动力学参数 总被引:1,自引:0,他引:1
本文建立了体液中右旋儿茶素的RP-HPLC测定方法。采用C_(18)键合相硅胶为填料的固相提取柱进行样品预处理,右旋儿茶素的提取回收率为79.8%.应用二极管阵列检测器对色谱峰纯度进行鉴定。该法精密度好,方法回收率近100%,日内、日间的变异系数为2.4~5.6%,血浓69.6~1160 ng/ml范围内呈线性关系,r=0.9993。家兔静注右旋儿茶素18mg/kg,其药代动力学过程符合二室模型,分布相半衰期为0.129 h,消除相半衰期为1.19h。 相似文献
10.
石杉碱甲类似物的研究II.N-甲基吡啶酮石杉碱甲类似物的合成 总被引:4,自引:1,他引:3
石杉碱甲(1)是从中草药石杉属植物千层塔(Lycopodium serratum Thunb.)中分得的一种高效可逆的乙酰胆碱酯酶抑制剂,临床试验证实它对早老性痴呆症有显著疗效。本文报道N-甲基吡啶酮石杉碱甲类似物2和3的合成。2-甲氧基-5-甲氧羰基-11-亚甲基-5,9-甲撑环辛-7-烯并吡啶(9)在乙腈中用三甲基氯硅烷和碘化钠选择性脱保护以定量的产率得吡啶酮10,再用甲醇钠和碘甲烷甲基化得N-甲基吡啶酮11,11经碱性水解,Curtius重排和氨基的脱保护得N-甲基吡啶酮石杉碱甲类似物2。通过类似的途径从中间体2-甲氧基-5-甲氧羰基-7-甲基-11-酮-5,9-甲撑环辛-7-烯并吡啶(14)合成了类似物3。类似物2和3的乙酰胆碱酯酶抑制活性均低于天然石杉碱甲。 相似文献